Status:
TERMINATED
The Optimal Dosage of Intrathecal Morphine for Peripartum Analgesia
Lead Sponsor:
Beth Israel Deaconess Medical Center
Conditions:
Labor Pain
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
The purpose of this study is to determine the ideal dosage of intrathecal morphine for intra and post partum analgesia, while minimizing the side effect profile.
Detailed Description
Regional anesthesia techniques such as combined spinal epidural (CSE) analgesia are very effective for the management of intrapartum pain. The advantages of these techniques are that they are safe whe...
Eligibility Criteria
Inclusion
- singleton pregnancy,
- at least 36 weeks gestational age,
- active labor (≤ 5 cm dilation) requesting neuraxial analgesia,
- ASA I or II,
- not currently taking pain medications.
Exclusion
- multiple gestation,
- preterm labor,
- systemic opioids in the past 4 hours,
- chronic pain syndromes,
- chronic opioid use,
- contraindications to regional anesthesia,
- allergies to opioids,
- significant co existing medical problems,
- severe pregnancy induced hypertension,
- sedatives,
- magnesium therapy,
- diabetes type 1.
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT01146457
Start Date
July 1 2010
End Date
January 1 2015
Last Update
April 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215